ImmBioApplying the science of ImmunoBiology to Healthcare
 

Future Relationships

The current portfolio has been selected to be attractive to partnerships, addressing major unmet needs and further information on specific partnership opportunities should at first be addressed to:
info@immbio.com

As both technology platforms have broad utility, ImmBio would consider entering into discussions on the potential fit across the anti-infective landscape, where there is a strong rationale on the utility of the technology platform.